ATS Blue Journal
@ATSBlueEditor
Followers
20K
Following
442
Media
5K
Statuses
8K
Posting content from the American Journal of Respiratory and Critical Care Medicine; follows do not indicate endorsement. #pulmCC #sleepmed #AJRCCM #RespEd #ATS
Joined December 2014
The Blue Journal thanks Astrid Blondeel, PhD, for her contribution to the December issue A Long-Term Physical Activity Coaching Program for Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial @BlondeelAstrid @troosters https://t.co/eNSjdDfqYa
0
0
1
Impact of Sleep Apnea on Perivascular Diffusivity and Cognition: A 4-Year Prospective Cohort Study @atscommunity 🔗 https://t.co/I901oPimQr
0
0
1
Perivascular Dynamics, Sleep Apnea, and Memory: Interpreting a Moving Target @atscommunity 🔓 Open Access 🔗
0
0
1
A Large-Scale Single-Cell Atlas Reveals the Peripheral Immune Panorama of Bacterial Pneumonia @atscommunity 🔓Open Access 🔗 https://t.co/7qXPGh4CFV
0
3
2
Think Locally, Act Globally: Resolving the Peripheral Immune Milieu in Bacterial Pneumonia @atscommunity 🔓 Open Access 🔗 https://t.co/WXQn9T4EyP
0
2
3
Big news for the ATS journals in 2026! ATS President @RaedDweikMD, MBA, ATSF, discusses the new partnership with @OUPAcademic in producing the ATS journals, all of which will now be online-only. Learn more about the ATS Journals: https://t.co/V5K21LMiXW
0
5
4
The Blue Journal thanks Vincent Geudens, MSc, for his contribution to the December issue Distinct Morphological Types of Small Airway Obstructions in Smokers with Emphysema and End-Stage Chronic Obstructive Pulmonary Disease https://t.co/mZAeos0Cdn
0
0
0
Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes RNASeq identifies distinct pulmonary features of ARDS molecular phenotypes @AartikSarma @ucsfccm @atscommunity 🔓 Open Access 🔗 https://t.co/jcFQ8FmT7U
0
3
6
Moving from Critical Illness Syndromes toward Biologic Molecular Endotypes: Making Progress @atscommunity 🔓 Open Access 🔗
0
0
2
For lung transplants, changes in priority, or scoring, have changed wait list mortality rates. Mary Raddawi, MD, of Columbia University Irving Medical Center, discusses the latest research showing how composite allocation scoring has helped save more lives. She joins guest Amy
0
4
1
The Blue Journal thanks Vincent Geudens, MSc, for his contribution to the December issue Distinct Morphological Types of Small Airway Obstructions in Smokers with Emphysema and End-Stage Chronic Obstructive Pulmonary Disease https://t.co/mZAeos0Cdn
0
0
0
Assessment of Respiratory Mechanics and Inspiratory Effort During Spontaneous Breathing Trials to Predict Extubation Failure in High-Risk Patients @atscommunity 🔓 Open Access 🔗 https://t.co/bKZhjTuaiI
0
8
39
The Blue Journal thanks Hayoung Choi, MD, PhD, ATSF, for his contribution to the December issue Upper-Airway Microbiome, Mucociliary Function, and Clinical Outcomes in Bronchiectasis: Data from the EMBARC-BRIDGE Study @ProfJDChalmers https://t.co/ch3XPtpP97
0
3
10
Is Measurement of Inspiratory Effort and Respiratory Mechanics before Ventilator Weaning a Step toward Personalized Medicine? @atscommunity 🔓 Open Access 🔗
0
0
1
A Long-Term Physical Activity Coaching Program for Patients with COPD Maintaining long-term physical activity in COPD is a challenge. This study compares intense vs light telecoaching @BlondeelAstrid @troosters @Demeyer_H 🔓 Open Access 🔗 https://t.co/NWLbwesrTJ
0
2
7
Can a Spark Light an Eternal Flame? Lessons from Physical Activity Coaching in Chronic Obstructive Pulmonary Disease @atscommunity 🔓 Open Access 🔗 https://t.co/0zoQ2Vm9UI
0
0
2
The Blue Journal thanks Melany Gaetani, MB, BCh, PhD(c), for her contribution to the December issue Environmental Sustainability in Intensive Care: From Awareness to Action https://t.co/h0fm7LE22x
1
0
2
The Blue Journal thanks Deepshikha Ashana, MD, MBA, MSCE, for her contribution to the December issue A Research Agenda to Mitigate Racial and Ethnic Disparities in U.S. Critical Care Medicine: An Official ATS Research Statement @dukemedicine https://t.co/iiuR2QeDkI
0
0
2
Randomized Sham-controlled Trial of Targeted Lung Denervation in Patients with Chronic Obstructive Pulmonary Disease (AIRFLOW-3) @atscommunity 🔓 Open Access 🔗 https://t.co/JUwNlXET0h
0
0
4
Targeted Lung Denervation in Chronic Obstructive Pulmonary Disease: Threading the Needle of Safe Interventions to Help the Sickest @atscommunity 🔓 Open Access 🔗
0
0
1